Translating legislative documents at the European Parliament: e-Parliament, XML, SPA and the Cat4Trad workflow

The translation services at the European Parliament, under the Directorate-General for Translation, use a chain of applications – e-Parliament – and XML technologies for the automation of the translation of legislative texts and efficient reuse of translated segments. This paper presents a detailed look at the translation workflow implemented at the European Parliament with focus on Safe Protocol Automation (SPA) and the Cat4Trad translation environment

Machine Translation and Neural Networks for a multilingual EU

This paper presents an overview of the current developments and use of Machine Translation (MT) and Neural Machine Translation (NMT), specifically eTranslation, in the European Institutions. An insight into the state-of-the-art of NMT as currently in development in the Directorate-General for Translation (DG TRAD) of the European Parliament is provided by Pascale Chartier-Brun. Problems in machine translation support requiring further research and development for processing languages with complex morphosyntax are discussed in the outlook. This paper was developed from the presentation “IT integrated environment for optimising the translation of legislative documents in the EP“ by Pascale Chartier-Brun at the workshop “Europäische Rechtslinguistik und Digitale Möglichkeiten / EU Legal Linguistics and Digital Perspectives“, held at the University of Cologne July 7th/8th, 2017

Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification

International audienceScedosporiosis/lomentosporiosis is a devastating emerging fungal infection. Our objective was to describe the clinical pattern and to analyze whether taxonomic grouping of the species involved was supported by differences in terms of clinical presentations or outcomes. We retrospectively studied cases of invasive scedosporiosis in France from 2005 through 2017 based on isolates characterized by polyphasic approach. We recorded 90 cases, mainly related to Scedosporium apiospermum (n = 48), S. boydii/S. ellipsoideum (n = 20), and Lomentospora prolificans (n = 14). One-third of infections were disseminated, with unexpectedly high rates of cerebral (41%) and cardiovascular (31%) involvement. In light of recent Scedosporium taxonomic revisions, we aimed to study the clinical significance of Scedosporium species identification and report for the first time contrasting clinical presentations between infections caused S. apiospermum, which were associated with malignancies and cutaneous involvement in disseminated infections, and infections caused by S. boydii, which were associated with solid organ transplantation, cerebral infections, fungemia, and early death. The clinical presentation of L. prolificans also differed from that of other species, involving more neutropenic patients, breakthrough infections, fungemia, and disseminated infections. Neutropenia, dissemination, and lack of antifungal prescription were all associated with 3-month mortality. Our data support the distinction between S. apiospermum and S. boydii and between L. prolificans and Scedosporium sp. Our results also underline the importance of the workup to assess dissemination, including cardiovascular system and brain. Lay Summary Scedosporiosis/lomentosporiosis is a devastating emerging fungal infection. Our objective was to describe the clinical pattern and to analyze whether taxonomic grouping of the species involved was supported by differences in terms of clinical presentations or outcomes